Onvansertib in combination with trastuzumab deruxtecan demonstrated enhanced antitumor activity, including tumor regression and apoptosis in HER2-low breast cancer models, supporting its potential for ...
Necrotic cell death is a fundamental biological process, yet the terminal execution mechanisms of necrosis are still not ...
Uveitis, which accounts for 10%–15% of blindness cases in developed nations and 25% in developing regions, represents a ...
A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...
Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in ...
Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, ...
How SARS-CoV-2 impacts astrocyte function in neurocovid-19 and what this means for brain health, neurological symptoms, and ...
Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast ...
An octopus-shaped nanomachine hijacks tumor ATP leakage to power a self-amplifying cycle of membrane damage, drug delivery, and metabolic collapse in cancer cells.